FILSPARI

SPARSENTAN · Travere Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for FILSPARI, covering 2023-02-17 to 2026-04-13. Get the full timeline:

Most recent: FDA Approved: FILSPARI — Supplemental Application (Travere Therapeutics, Inc.)